Column Group IV GP, LP — SEC insider filings
SEC reporting owner CIK 1796356. 29 insider filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2022-01-26 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 74 legs across 27 filings — 7,175,891 shares, $80,442,684 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: purchase of 1,437,323 shares @ $18.00 ($25,871,814) in Eikon Therapeutics, Inc., filed 2026-02-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. (EIKN) | 10% owner | 2 | 4 legs · 2,206,960 sh · $39,150,725 | — | 14 |
| NGM BIOPHARMACEUTICALS INC (NGM) | 10% owner | 23 | 62 legs · 3,690,481 sh · $27,605,175 | — | 14 |
| RAPT Therapeutics, Inc. (RAPT) | 10% owner | 4 | 8 legs · 1,278,450 sh · $13,686,784 | — | 4 |
Insider filings — Column Group IV GP, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Eikon Therapeutics, Inc. (EIKN) jointly with Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Purchase (P): 89,200 @ $11.56 | EDGAR |
| 2026-02-09 | 4 | Eikon Therapeutics, Inc. (EIKN) jointly with Column Group IV-A, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Conversion (C): 1,296,629 · Conversion (C): 1,403,568 · Conversion (C): 110,928 · Conversion (C): 44,249 · Conversion (C): 47,898 · Conversion (C): 3,785 · +11 more | EDGAR |
| 2024-12-23 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Other (J): 1,352,008 · Other (J): 1,599,417 · Other (J): 1,352,008 (derivative) · Other (J): 1,599,417 (derivative) | EDGAR |
| 2024-04-08 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 more | EDGAR |
| 2023-11-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 16,791 @ $0.71 · Purchase (P): 5,840 @ $0.62 | EDGAR |
| 2023-02-01 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 7,542 @ $5.00 · Purchase (P): 176,730 @ $5.00 | EDGAR |
| 2023-01-25 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 9,900 @ $5.00 | EDGAR |
| 2023-01-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 37,639 @ $5.00 · Purchase (P): 500 @ $5.00 | EDGAR |
| 2023-01-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 5,378 @ $4.95 | EDGAR |
| 2023-01-12 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 100,070 @ $4.84 · Purchase (P): 209,000 @ $4.76 | EDGAR |
| 2022-12-14 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 300 @ $4.98 | EDGAR |
| 2022-11-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 35,997 @ $5.00 · Purchase (P): 4,330 @ $5.00 | EDGAR |
| 2022-11-07 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 104,090 @ $4.99 · Purchase (P): 35,058 @ $4.72 | EDGAR |
| 2022-10-31 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 76,877 @ $4.86 | EDGAR |
| 2022-10-27 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Purchase (P): 51,046 @ $4.75 · Purchase (P): 72,774 @ $4.85 | EDGAR |
| 2022-06-13 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 951,684 @ $13.50 · Purchase (P): 32,477 @ $13.50 | EDGAR |
| 2022-06-06 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 33,071 @ $13.03 · Purchase (P): 1,129 @ $13.03 | EDGAR |
| 2022-06-02 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 59,766 @ $13.47 · Purchase (P): 2,040 @ $13.47 · Purchase (P): 88,964 @ $13.45 · Purchase (P): 3,036 @ $13.45 | EDGAR |
| 2022-05-31 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 19,534 @ $13.49 · Purchase (P): 667 @ $13.49 · Purchase (P): 2,621 @ $13.45 · Purchase (P): 89 @ $13.45 | EDGAR |
| 2022-05-27 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 1,837 @ $12.45 · Purchase (P): 63 @ $12.45 | EDGAR |
| 2022-05-26 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 17,240 @ $13.37 · Purchase (P): 588 @ $13.37 · Purchase (P): 41,863 @ $13.43 · Purchase (P): 1,429 @ $13.43 | EDGAR |
| 2022-05-25 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 9,898 @ $12.50 · Purchase (P): 338 @ $12.50 · Purchase (P): 15,776 @ $12.00 · Purchase (P): 538 @ $12.00 | EDGAR |
| 2022-05-23 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 19,984 @ $13.25 · Purchase (P): 682 @ $13.25 · Purchase (P): 18,406 @ $13.48 · Purchase (P): 628 @ $13.48 | EDGAR |
| 2022-05-19 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 86,110 @ $13.42 · Purchase (P): 2,939 @ $13.42 · Purchase (P): 60,583 @ $13.20 · Purchase (P): 2,067 @ $13.20 | EDGAR |
| 2022-05-17 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 125,096 · Purchase (P): 4,269 · Purchase (P): 32,072 @ $12.90 · Purchase (P): 1,094 @ $12.90 | EDGAR |
| 2022-05-13 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 77,866 @ $11.23 · Purchase (P): 2,657 @ $11.23 · Purchase (P): 2,564 @ $11.85 · Purchase (P): 88 @ $11.85 · Purchase (P): 79,945 @ $11.62 · Purchase (P): 2,728 @ $11.62 · +2 more | EDGAR |
| 2022-05-12 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 1,208,750 @ $10.67 · Purchase (P): 41,250 @ $10.67 | EDGAR |
| 2022-05-11 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 80,430 @ $10.79 · Purchase (P): 2,745 @ $10.79 · Purchase (P): 30,233 @ $11.36 · Purchase (P): 1,032 @ $11.36 | EDGAR |
| 2022-01-26 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP L P, COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, Column Group IV, LP, Column Group IV-A, LP, TCG IV GP, LLC | Purchase (P): 241,750 · Purchase (P): 8,250 · Purchase (P): 579,910 · Purchase (P): 19,791 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-01-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796356 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs